[Skip to Navigation]
Comment & Response
June 10, 2020

Clarification Regarding Noninferiority and a Discussion of Model Selection and Treatment Effects in Observational Research

Author Affiliations
  • 1Department of Dermatology, Broward Health, Fort Lauderdale, FL
  • 2Department of Population Health Sciences, University of Utah, Salt Lake City
JAMA Dermatol. 2020;156(9):1028-1029. doi:10.1001/jamadermatol.2020.1310

To the Editor We read with interest the recent article by Cheraghlou et al1 comparing overall survival among patients with stage I melanoma receiving Mohs micrographic surgery (MMS) or wide margin excision (WME). Although we agree that these data potentially support the use of MMS in patients with stage I tumors, we point out an erroneous use of the term noninferiority and suggest a significant limitation not mentioned.

Add or change institution